David E. Lazar - Jul 6, 2022 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
10%+ Owner
Signature
/s/ David E. Lazar
Stock symbol
TTNP
Transactions as of
Jul 6, 2022
Transactions value $
$1,922,882
Form type
4
Date filed
7/8/2022, 06:00 PM
Next filing
Jan 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTNP Common Stock, par value $0.001 Purchase $902K +1.17M +82.05% $0.77 2.59M Jul 6, 2022 Direct F1, F2, F3
transaction TTNP Common Stock, par value $0.001 Purchase $739K +744K +28.77% $0.99 3.33M Jul 7, 2022 Direct F1, F2, F4
transaction TTNP Common Stock, par value $0.001 Purchase $282K +316K +732.23% $0.89 359K Jul 6, 2022 By Activist Investing LLC F1, F2, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
F2 Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
F3 Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.5982 to $0.9964. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
F4 Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.8399 to $1.1000. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
F5 Securities of the Issuer beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.
F6 Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.6640 to $0.9499. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.